๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thrombocytopenia

Apixaban in Thrombocytopenia NCT06886516EARLY Phase 11 site๐Ÿ“ Boston Rushad Patell ยท Tests: Apixaban A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia NCT06776510Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: nicotinamide adenine dinucleotid/nicotinamide mononucleotide Investigation of the Genetics of Hematologic Diseases NCT02720679n/a1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial NCT06992128Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Romiplostim N01 combined with dexamethasone, Dexamethasone monotherapy Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) NCT07234019Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Daratumumab๏ผˆAnti-CD38 Monoclonal Antibody๏ผ‰, Rituximab Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders NCT07104565Phase 239 sites๐Ÿ“ Glendale๐Ÿ“ Los Angeles๐Ÿ“ Lone Tree Incyte Corporation ยท Tests: INCA000585 A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP) NCT06094881Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Obinutuzumab Injection [Gazyva] Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia NCT06281327Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Avatrombopag Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP) NCT06838962Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Daratumumab Injection A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT) NCT07286032Phase 351 sites๐Ÿ“ Long Beach๐Ÿ“ Los Alamitos๐Ÿ“ Los Angeles Jiangsu HengRui Medicine Co., Ltd. ยท Tests: Hetrombopag Olamine, Hetrombopag Olamine; Hetrombopag Olamine Placebo The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) NCT07065968Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Teriflunomide, Dexamethasone CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: UCAR T-cell Platelet-Directed Whole Blood Transfusion Strategy for Malaria NCT05711485NA2 sites๐Ÿ“ Baltimore๐Ÿ“ Ndola Johns Hopkins Bloomberg School of Public Health ยท Tests: Whole blood transfusion Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA NCT05855083Phase 216 sites๐Ÿ“ San Diego๐Ÿ“ Gainesville๐Ÿ“ Boston Omeros Corporation ยท Tests: Biological: narsoplimab CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases NCT07315087Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: QT-019C Construction of a Database for TMA NCT05634928n/a1 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: collection data An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases NCT07174843EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Cell Therapy Group Co.,Ltd ยท Tests: CD19/CD22/BCMA CAR-T cells(BZE2204) SG301-SC Injection Safety Study in Subjects With Primary ITP Patients NCT07710248Phase 222 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Liuzhou Hangzhou Sumgen Biotech Co., Ltd. ยท Tests: low dose group, high dose group, Placebo group Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: data collection BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia NCT07394153Phase 213 sites๐Ÿ“ Barcelona๐Ÿ“ Barcelona๐Ÿ“ Barcelona Grupo Espaรฑol de Enfermedades Mieloproliferativas Crรณnicas โ€ฆ ยท Tests: Pacritinib OM336 in Autoimmune Cytopenias NCT07083960Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ Washington D.C.๐Ÿ“ Ann Arbor Lakefront Biotherapeutics West LLC ยท Tests: OM336 Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients NCT07059026n/a1 site๐Ÿ“ Buenos Aires ITAC (Instituto de Trasplantes y Alta Complejidad) Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura NCT04323748Phase 11 site๐Ÿ“ Vahalla New York Medical College ยท Tests: rituxan QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia NCT06456528Phase 2, Phase 32 sites๐Ÿ“ Harbin๐Ÿ“ Nanjing Qilu Pharmaceutical Co., Ltd. ยท Tests: QL0911, QL0911 plus Placebo, Placebo Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) NCT07362199Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Rituximab combined with Daratumumab๏ผˆAnti-CD38 Monoclonal Antibody๏ผ‰ Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura NCT07093606NA1 site๐Ÿ“ Sohag Sohag University ยท Tests: Eltrombopag Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia NCT06826430Phase 11 site๐Ÿ“ Beijing Juventas Cell Therapy Ltd. ยท Tests: Inaticabtagene autoleucel Injection Genomics and COVID-19 Vaccine Adverse Events NCT05212792n/a1 site๐Ÿ“ Vancouver University of British Columbia ยท Tests: COVID-19 vaccines Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort Study NCT07757789NA1 site๐Ÿ“ Al Khฤrjah New Valley University ยท Tests: Platelet count
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy